Hemostemix Inc (HEM)

Currency in CAD
0.0750
-0.0050(-6.25%)
Closed·
Earnings results expected in 9 days
HEM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.07500.0750
52 wk Range
0.04000.1350
Key Statistics
Prev. Close
0.08
Open
0.075
Day's Range
0.075-0.075
52 wk Range
0.04-0.135
Volume
5.63K
Average Volume (3m)
25.75K
1-Year Change
-6.25%
Book Value / Share
-0.03
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HEM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Hemostemix Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Earnings

Latest Release
28-05-2026
EPS / Forecast
-0.01 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

HEM Income Statement

Compare HEM to Peers and Sector

Metrics to compare
HEM
Peers
Sector
Relationship
P/E Ratio
−3.5x−2.1x−0.3x
PEG Ratio
−0.110.000.00
Price/Book
−2.7x−1.9x2.6x
Price / LTM Sales
-1.3x3.1x
Upside (Analyst Target)
-135.1%47.6%
Fair Value Upside
Unlock−2.4%5.6%Unlock

Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which completed Phase II clinical trial for the treatment of peripheral arterial disease, chronic limb threatening ischemia, cardiovascular ischemia and angina, and vascular dementia. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
23.76M12.01%1.90M
Public Companies & Retail Investors
174.06M87.99%13.92M
Total
197.82M100.00%15.83M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Summerhill Investment Corp12.01%2,37,60,0001,901

FAQ

What Is the Hemostemix Inc (HEM) Share Price Today?

The Hemostemix Inc share price today is 0.0750.

What is the current Hemostemix Inc (HEM) share price and day range?

As of 22-08-2026, the Hemostemix Inc share price is 0.0750, with a previous close of 0.0800. The share price has ranged from 0.0750 to 0.0750 today, while the 52-week range spans from 0.0400 to 0.1350.

What Is the Hemostemix Inc Market Cap?

As of today, Hemostemix Inc market cap is 15.8300M.

What Is Hemostemix Inc's Earnings Per Share (TTM)?

The Hemostemix Inc EPS (TTM) is -0.0234.

When Is the Next Hemostemix Inc Earnings Date?

Hemostemix Inc will release its next earnings report on 31-08-2026.

From a Technical Analysis Perspective, Is HEM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

What Stock Exchange Does Hemostemix Inc Trade On?

Hemostemix Inc is listed and trades on the TSX Venture Exchange.

What Is the Stock Symbol for Hemostemix Inc?

The stock symbol for Hemostemix Inc is "HEM."

How Many Times Has Hemostemix Inc Stock Split?

Hemostemix Inc has split 2 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.